By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?
about
Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention.Cervical cancer screening cotesting with cytology and MRNA HPV E6/E7 yields high rates of CIN2+ lesions in young women.Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study.
P2860
By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
By how much could screening by ...... l cancer incidence in England?
@ast
By how much could screening by ...... l cancer incidence in England?
@en
type
label
By how much could screening by ...... l cancer incidence in England?
@ast
By how much could screening by ...... l cancer incidence in England?
@en
prefLabel
By how much could screening by ...... l cancer incidence in England?
@ast
By how much could screening by ...... l cancer incidence in England?
@en
P2860
P50
P356
P1476
By how much could screening by ...... l cancer incidence in England?
@en
P2860
P304
P356
10.1177/0969141316654197
P577
2016-06-30T00:00:00Z